Abstract:Using an unsupervised weighted gene correlation analysis on blood transcriptomes pre‐ and post‐COVID‐19 mRNA vaccination, we identify distinct gene networks that are up‐ and downregulated in response to vaccination. A particular interferon‐associated network significantly correlated with induced antibody levels and was further characterized, for example, by identifying network hub genes. Messenger RNA (mRNA) vaccines represent a new class of vaccines that has been shown to be highly effective during the COVID‐19 pandemic and that holds great potential for other preventative and therapeutic applications. While it is known that the transcriptional activity of various genes is altered following mRNA vaccination, identifying and studying gene networks could reveal important scientific insights that might inform future vaccine designs. In this study, we conducted an in‐depth weighted gene correlation network analysis of the blood transcriptome before and 24 h after the second and third vaccination with licensed mRNA vaccines against COVID‐19 in humans, following a prime vaccination with either mRNA or ChAdOx1 vaccines. Utilizing this unsupervised gene network analysis approach, we identified distinct modular networks of co‐varying genes characterized by either an expressional up‐ or downregulation in response to vaccination. Downregulated networks were associated with cell metabolic processes and regulation of transcription factors, while upregulated networks were associated with myeloid differentiation, antigen presentation, and antiviral, interferon‐driven pathways. Within this interferon‐associated network, we identified highly connected hub genes such as STAT2 and RIGI and associated upstream transcription factors, potentially playing important regulatory roles in the vaccine‐induced immune response. The expression profile of this network significantly correlated with S1‐specific IgG levels at the follow‐up visit in vaccinated individuals. Those findings could be corroborated in a second, independent cohort of mRNA vaccine recipients. Collectively, results from this modular gene network analysis enhance the understanding of mRNA vaccines from a systems immunology perspective. Influencing specific gene networks could lead to optimized vaccines that elicit augmented vaccine responses.

Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID‐19

Time‐series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS‐CoV‐2 mRNA vaccine

Weighted gene co-expression network-based identification of genetic effect of mRNA vaccination and previous infection on SARS-CoV-2 infection

Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans

BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant

Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice

Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine

Analysing Transcriptomic Signatures and Identifying Potential Genes for the Protective Effect of Inactivated COVID-19 Vaccines.

Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines

Identification of dynamic gene expression profiles during sequential vaccination with ChAdOx1/BNT162b2 using machine learning methods

Single-cell transcriptomic atlas of individuals receiving inactivated COVID-19 vaccines reveals distinct immunological responses between vaccine and natural SARS-CoV-2 infection

High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals

Single‐cell transcriptome atlas reveals protective characteristics of COVID‐19 mRNA vaccine

Early human B cell signatures of the primary antibody response to mRNA vaccination

Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity

Single‐cell transcriptomic atlas reveals distinct immunological responses between COVID‐19 vaccine and natural SARS‐CoV‐2 infection

Longitudinal Proteomic Investigation of COVID-19 Vaccination

Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine

Single-cell Transcriptome Landscape and Antigen Receptor Dynamic During SARS-CoV-2 Vaccination

Humoral Immunity after mRNA Omicron JN.1 Vaccination

Deep, unbiased and quantitative mass spectrometry-based plasma proteome analysis of individual responses to mRNA COVID-19 vaccine